Amgen Argues Decade-Old Derivative Suit Still Lacks Facts
Amgen Inc. told a California judge Monday that a decade-old action claiming the company's board caused more than $1 billion in damages by overseeing an off-label marketing scheme lacked facts to...To view the full article, register now.
Already a subscriber? Click here to view full article